Kura Oncology, Inc.
KURA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001422143
In the last 90 days, Kura Oncology, Inc. insiders filed 2 open-market purchases and 8 sales; 221 institutions reported holding it in 13F filings for Q2 2026, worth $953.1M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Kura Oncology, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Of which not filed for Q2 2021 | Q2 2021 | Change |
|---|---|---|---|---|
| Holders | 171 | 1 | 171 | +1 |
| Shares | 68.6M | 16.5K | 67.6M | −948.9K (−1.4%) |
| Value | $1.94B | $467.0K | $1.41B | −$532.0M (−27.4%) |
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Kura Oncology, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 1,794,000 | $37.4M | 0.66% |
| Great Point Partners LLC | 500,000 | $10.4M | 2.33% |
| Renaissance Technologies LLC | 302,200 | $6.30M | 0.01% |
| Woodline Partners LP | 267,683 | $5.58M | 0.10% |
| Rubric Capital Management LP | 231,481 | $4.83M | 0.31% |
| Phoenix Holdings Ltd. | 95,000 | $1.98M | 0.04% |
| Hudson Bay Capital Management LP | 80,000 | $1.67M | 0.02% |
| Cubist Systematic Strategies, LLC | 65,831 | $1.37M | 0.02% |
| Engineers Gate Manager LP | 30,469 | $635.0K | 0.04% |
| Walleye Capital LLC | 20,990 | $438.0K | 0.02% |
| Twinbeech Capital LP | 19,901 | $415.0K | 0.05% |
| Voloridge Investment Management, LLC | 14,592 | $304.0K | 0.00% |
| Jump Financial, LLC | 10,700 | $223.0K | 0.02% |
| ExodusPoint Capital Management, LP | 10,472 | $218.0K | 0.00% |
| Caption Management, LLC | 4,600 | $96.0K | 0.01% |
| Point72 Hong Kong Ltd | 3,392 | $71.0K | 0.00% |
| FORA Capital, LLC | 1,316 | $27.0K | 0.01% |
| Advisory Services Network, LLC | 500 | $10.0K | 0.00% |
| Evoke Wealth, LLC | 77 | $2.00K | 0.00% |
| Captrust Financial Advisors | 26 | $1.00K | 0.00% |
| Rockefeller Capital Management L.P. | 29 | $0 | 0.00% |
Sold out (20)
Institutions that held Kura Oncology, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| RTW Investments, LP | 1,081,912 | $30.6M |
| Asymmetry Capital Management, L.P. | 277,468 | $7.84M |
| California Public Employees Retirement System | 122,976 | $3.48M |
| Compagnie Lombard Odier SCmA | 104,293 | $2.95M |
| Bailard, Inc. | 81,934 | $2.32M |
| Connacht Asset Management LP | 77,501 | $2.19M |
| Aviva PLC | 48,073 | $1.36M |
| Ensign Peak Advisors, Inc | 35,339 | $999.0K |
| Ikarian Capital, LLC | 15,603 | $441.0K |
| AQR Capital Management LLC | 12,875 | $364.0K |
| Amalgamated Bank | 8,831 | $250.0K |
| Ovata Capital Management Ltd | 7,000 | $198.0K |
| Exane Derivatives | 4,606 | $130.2K |
| STRS Ohio | 3,100 | $87.0K |
| Pacer Advisors, Inc. | 2,618 | $74.0K |
| Bank of Montreal | 2,218 | $63.0K |
| TCI Wealth Advisors, Inc. | 64 | $2.00K |
| Assetmark, Inc | 18 | $1.00K |
| Alpha DNA Investment Management LLC | 41 | $1.00K |
| Meridian Wealth Partners, LLC | 11 | $0 |
Not filed for Q2 2021 yet (1)
Institutions that held Kura Oncology, Inc. at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Pillar Pacific Capital Management LLC | 16,500 | $467.0K |